Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands
- PMID: 23855503
- DOI: 10.1111/bjd.12507
Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands
Abstract
Background: Photodynamic therapy (PDT) is a well-documented treatment for actinic keratosis (AK), but achieves inferior efficacy in organ transplant recipients (OTRs), particularly in acral regions. Ablative fractional laser (AFXL) intensifies the PDT response and may improve the efficacy of AK clearance when used as monotherapy.
Objectives: To compare the efficacy of a single treatment with AFXL-assisted PDT vs. AFXL alone for difficult-to-treat AKs and wart-like lesions (WLLs) in OTRs.
Methods: Ten OTRs were included with a total of 680 AKs (severity grade I-III) and 409 WLLs on the dorsal hands. Both hands were initially treated with targeted fractional ablation of thick keratotic lesions followed by AFXL field treatment. Treatment regions were then randomized to (i) PDT (AFXL-PDT) or (ii) no further treatment (AFXL). The primary end point was complete response (CR) at 4 months after treatment; secondary end points were improvement of AK severity grade, overall patient assessment of efficacy and tolerability of treatments.
Results: CR of AKs was significantly higher for AFXL-PDT (73%) compared with AFXL alone (31%) (P = 0·002). AFXL-PDT improved 82% of AKs to lower lesion grades compared with 52% after AFXL alone (P = 0.008). For WLLs, the rate of CR was 37% for AFXL-PDT compared with 14% for AFXL (P = 0·02). Overall assessment showed a preference for AFXL-PDT compared with AFXL (AFXL-PDT, n = 8; AFXL, n = 0; equal, n = 2). Mild pigment changes were observed in four patients (AFXL-PDT, n = 3; AFXL, n = 1). No scarring was observed.
Conclusions: AFXL-PDT is more effective than AFXL in the treatment of acral AKs and WLLs in OTRs.
© 2013 British Association of Dermatologists.
Similar articles
-
Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.Br J Dermatol. 2012 Jun;166(6):1262-9. doi: 10.1111/j.1365-2133.2012.10893.x. Br J Dermatol. 2012. PMID: 22348388 Clinical Trial.
-
Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis.Photodermatol Photoimmunol Photomed. 2015 Nov;31(6):296-301. doi: 10.1111/phpp.12184. Epub 2015 Jun 17. Photodermatol Photoimmunol Photomed. 2015. PMID: 26012779 Clinical Trial.
-
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.Br J Dermatol. 2018 Apr;178(4):903-909. doi: 10.1111/bjd.15884. Epub 2018 Feb 5. Br J Dermatol. 2018. PMID: 28796885 Clinical Trial.
-
Local interventions for actinic keratosis in organ transplant recipients: a systematic review.Br J Dermatol. 2019 Jan;180(1):43-50. doi: 10.1111/bjd.17148. Epub 2018 Oct 31. Br J Dermatol. 2019. PMID: 30188570
-
Photodynamic therapy for actinic keratosis in organ transplant patients.J Eur Acad Dermatol Venereol. 2013 Jan;27(1):57-66. doi: 10.1111/j.1468-3083.2011.04356.x. Epub 2011 Dec 10. J Eur Acad Dermatol Venereol. 2013. PMID: 22151793 Review.
Cited by
-
Laser-assisted drug delivery in dermatology: from animal models to clinical practice.Lasers Med Sci. 2016 Feb;31(2):373-81. doi: 10.1007/s10103-015-1853-z. Epub 2015 Dec 22. Lasers Med Sci. 2016. PMID: 26694489 Review.
-
Efficacy and Safety of Fractional CO2 Laser Combined with Halometasone Cream for Treatment of Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized Trial.Dermatol Ther (Heidelb). 2023 Aug;13(8):1789-1799. doi: 10.1007/s13555-023-00944-w. Epub 2023 Jun 24. Dermatol Ther (Heidelb). 2023. PMID: 37354295 Free PMC article.
-
Laser-mediated Solutions: Breaking Barriers in Transdermal Drug Delivery.AAPS PharmSciTech. 2024 Jun 19;25(6):142. doi: 10.1208/s12249-024-02849-z. AAPS PharmSciTech. 2024. PMID: 38898170 Review.
-
Photodynamic therapy in dermatology beyond non-melanoma cancer: An update.Photodiagnosis Photodyn Ther. 2017 Sep;19:140-152. doi: 10.1016/j.pdpdt.2017.06.010. Epub 2017 Jun 21. Photodiagnosis Photodyn Ther. 2017. PMID: 28647616 Free PMC article. Review.
-
Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events.Pharmaceutics. 2022 Dec 7;14(12):2738. doi: 10.3390/pharmaceutics14122738. Pharmaceutics. 2022. PMID: 36559233 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical